Sanders targets pharma CEOs to testify in Senate, but some see 'retaliation' for lawsuit against Biden admin
Fox News
Sen. Bernie Sanders plans a Jan. 31 vote to subpoena Pharma CEOs for a drug pricing hearing after they declined last year, citing "unacceptable" refusal and questioning high costs compared to other countries.
Jamie Joseph is a writer who covers politics. She leads Fox News Digital coverage of the Senate.
But some executives see the pending subpoenas as a form of retaliation for a court battle over Medicare price negotiations.
"It is absolutely unacceptable that the CEOs of Johnson & Johnson and Merck have refused an invitation by a majority of members on the HELP Committee to appear before Congress about the outrageously high price of prescription drugs," Sanders said. "These CEOs may make tens of millions of dollars in compensation. The pharmaceutical companies they run may make billions in profits."